Skip to main content

CORRECTION: Diagnostic Hybrids Corrects Statement on FDA H1N1 Test Claims

This artcile has been updated following a correction issued by Diagnostic Hybrids on Sep. 2.

NEW YORK (GenomeWeb News) – Diagnostic Hybrids on Wednesday issued a correction to an earlier statement and said that the US Food and Drug Administration has not cleared any additional claims or new intended uses for its respiratory virus test kit.

The Athens, Ohio-based firm said that its D3 Ultra DFA Respiratory Virus Identification Kit is the only monoclonal antibody-based screening kit commercially available that can detect and identify influenza A virus, as well as influenza B virus, respiratory syncytial virus, adenovirus, and parainfluenza virus types 1, 2, and 3.

Diagnostic Hybrids said that although the kit has shown that it could detect the 2009 influenza A (H1N1)v virus in two culture isolates, "the performance characteristics of this device with clinical specimens that are positive for the 2009 influenza A (H1N1)v virus have not been established. The D3 Ultra kit can distinguish between influenza A and B viruses, but it cannot differentiate influenza subtypes," the firm added in a statement.

Diagnostic Hybrids' announcement comes one week after Prodesse said that FDA had cleared additional claims for its ProFlu+ assay, which says that it correctly identifies as Influenza A positive specimens containing novel 2009 H1N1 influenza virus.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.